June 27, 2024 – Importance of FACIT and other seed stage venture groups in building the local innovation ecosystem. Life sciences commercialization in Canada has a seed venture financing gap where companies fail to establish local roots and intellectual property gravitates to the US, reinforcing the export of jobs and industry experience.
Tag: seed capital
Cutting-edge radiosurgery tech for brain tumours wins 2024 Falcons’ Fortunes
May 6, 2024 – At the sold-out Falcons’ Fortunes pitch competition hosted by FACIT, Dr. Hatim Fakir delivered the winning pitch as selected by the panel of judges for the $100,000 Ernsting Entrepreneurship Award. Developed at London Health Sciences Centre, Dr. Fakir’s RadioSphere is a patient-centred technology to revolutionize existing gamma knife radiotherapy procedures by providing the most precise tumour localization capabilities.
Read More from Cutting-edge radiosurgery tech for brain tumours wins 2024 Falcons’ Fortunes
FACIT and OBIO® partner on women-focused seed capital and entrepreneurship program
March 8, 2024 – On International Women’s Day, FACIT and OBIO® are pleased to announce a new partnership in the Ontario life sciences ecosystem, built on their common goal to drive entrepreneurial and commercialization mandates to address the unmet needs and barriers faced by female entrepreneurial leaders in STEM.
Read More from FACIT and OBIO® partner on women-focused seed capital and entrepreneurship program
FACIT’s Prospects Fund invests in two emerging Ontario diagnostics for colorectal and prostate cancers
September 16, 2021 – September 16, 2021 – Both innovations were previous finalists in FACIT’s 2021 Falcons’ Fortunes pitch competition.
FACIT leads seed round in Nanology Labs
May 18, 2021 – May 18, 2021 – FACIT deploys Ontario First capital, enables rising local start-up to reach critical value inflection point. FACIT has previously supported Nanology, spun out of the University of Toronto, through both its early-stage Prospects Oncology Fund and seed-stage Compass Rose Oncology Fund.
FACIT crowns 2021 winner of Falcons’ Fortunes pitch competition; announces follow-on investment in 2020 winner, Bridge7 Oncology
February 4, 2021 – February 4, 2021 – FACIT’s Prospects Oncology Fund and its annual pitch competition help to advance Ontario oncology innovations.
FACIT fuels promising made-in-Ontario breast cancer therapeutic and medtech innovations through Prospects Oncology Fund
December 10, 2020 – December 10, 2020 – The newest recipients of Ontario First seed capital include Dr. Rebecca Laposa of the University of Toronto, as well as London-based start-up Multi-Magnetics Inc.
FACIT announces follow-on investments in Xpan Inc. and Nanology Labs through Compass Rose Fund
January 28, 2020 – January 28, 2020 – Spun out of the University of Toronto, both start-ups have previously received funding through FACIT’s proof-of-concept Prospects Fund.
FACIT Announces Investment in 3 Ontario Start-ups Under Prospects Fund
July 10, 2017 – Ontario start-ups Radialis Medical of Thunder Bay, KA Imaging of Kitchener, and DNAstack of Toronto are the first to receive capital from FACIT’s new Prospects Oncology Fund for proof-of-concept development of breakthrough cancer technologies.
Read More from FACIT Announces Investment in 3 Ontario Start-ups Under Prospects Fund